Read the story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Last hour:
Last 24 hours:

Gilead says remdesivir drug unaffected by new strains of coronavirus

% of readers think this story is Fact. Add your two cents.

Gilead Sciences Inc (NASDAQ:GILD) earnings beat forecasts as sales of its antiviral drug remdesivir were boosted by its use as a treatment for coronavirus (COVID-19).

Remdesivir is now treating one in two hospitalised patients in the United States, said the NASDAQ-listed drug group.

Sales in the fourth quarter rose by 26% to US$7.3bn even though the impact of COVID-19 affected sales of other drugs for hepatitis C and HIV as fewer people went to the see their doctors.

Excluding remdesivir, which is sold under the brand name Veklury, sales fell 7% in the quarter said Gilead.

Remsdesivir revenues rose to US$1.9bn in the three months to end-December 2020, compared to market expectations of about US$1.3bn.

Underlying earnings in the three month period rose by 99% to US2.19 per share.

The company said remdesivir remains a key treatment for people suffering from COVID-19 and predicted sales in 2021 would be up to US$3bn.

In a call, Merdad Parsey, Gilead chief medical officer, said that so far none of the mutations of the virus seen in the UK and South Africa have had an impact on the drug’s effectiveness

Remdesivir does not target the spike proteins of the coronavirus, he said, which are altered in these variants of the virus.

“We have not so far seen mutations that would impact the efficacy of remdesivir,” Parsey added.

Gilead said it is continuing to work on an inhaled version of the COVID-19 drug that is currently given intravenously.

For full-year 2020, revenues rose 10% to US$24.7bn while underlying earnings rose 16% to US$7.09 per share.

For 2021, revenues are forecast by the company in a range of US$23.7bn-25.1bn with underlying earnings US$6.75-7.45 per share.

“As we head into 2021, we have many additional opportunities to help patients, especially in oncology where Trodelvy, for example, has the potential to treat a broad range of cancer types,” the company added.

Story by ProactiveInvestors


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!

Order by Phone at 888-809-8385 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse


    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    Load more ...




    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.